Research report that investigates the challenges associated with determining a fair value assessment for embedded options in two product types, explains period-to-period changes in value and discusses incorporating these values into financial projections and product pricing.

In this paper we derive some results on the dividend payments prior to ruin in a Markov modulated risk process in which the rate for the Poisson claim arrival process and the distribution of the claim sizes vary in time depending on the state of an underlying external Markov jump process. From NAAJ, April 2007, Volume 11, Number 2.

Handouts from a session at the US GAAP for International Life Insurers SOA conference held in Shanghai on June 2008. The session focused on Mergers/Acquisitions and the use of Purchase Accounting for the consummation of and future financial results from the transaction. Covers APB 16, 17 and SFAS 141, 142, liability accounting under SFAS 60, 97, and 120 and the calculation of value of business acquired VOBA.

2011 Valuation Actuary Symposium, Orlando. This session discussed Embedded Value and Market Consistent Embedded Value. Topics included: 1. Methodology and assumptions. 2. 2010 operating results. 3. 2010 value of new business. 4. Future of MCEV post Solvency II. 5. Value of new business.

2011 Valuation Actuary Symposium, Orlando. Panelists discussed embedded value and market consistent embedded value. Topics included: 1. General principles and background of EV and MCEV. 2. Methodology and assumptions. 3. 2010 operating results. 4. MCEV components. 5. Value of new business. 6. Assumption setting. 7. Controls required for model-based valuation.

Presentation at Valuation Actuary Symposium September 2009. This follow-up workshop will discuss the current status of Embedded Value and Market Consistent Embedded Value, performance in extreme markets and implementation issues.

Presentation at SOA Annual Meeting October 2009. Insurers are finding that in order to be competitive, they must sell fixed annuities with negative market-consistent embedded value. Presenters will explore whether this makes sense and what it implies for investment strategies.

Presentation from 2009 Health Spring Meeting which discussed the theory behind and application of Market Consistent Embedded Value. The presentations describe how utilizing the approach may cause companies to realign their strategies and new business management.

Discusses the pros and cons of performance-assessment bases, including market-consistent embedded value [MCEV], proposed new International Financial Reporting Standards [IFRS], and cost-of-funds embedded value [EV], which are designed to provide useful information on where value is created and which business units are creating the value. There is no presentation included from Eric Berg. Session # 123 PD from the 2010 Society of Actuaries Annual Meeting and Exhibit in New York.

2011 Valuation Actuary Symposium, Orlando. This session discussed market trends with European Embedded Value and Market Consistent Embedded Value. Topics included: 1. How European Embedded Value and Market Consistent Embedded Value have evolved. 2. Recent MCEV disclosures. 3. The recent MCEV practice note. 4. Latest CFO Forum recommendations. 5. How has the financial crisis impacted EEV/MCEV reporting? 6. Key considerations in implementing MCEV. 7. Link to economic capital/performance measurement. 8. Use in making business decisions.